Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$150.93
+0.8%
$141.81
$108.46
▼
$157.29
$185.61B0.335.64 million shs5.28 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$150.93
+0.8%
$141.81
$108.46
▼
$157.29
$185.61B0.335.64 million shs5.28 million shs
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$201.97
+4.0%
$170.18
$121.99
▼
$259.92
$204.02B1.6813.68 million shs17.80 million shs
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$160.48
-1.0%
$159.68
$110.39
▼
$176.41
$672.06B0.1813.97 million shs10.94 million shs
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$160.48
-1.0%
$159.68
$110.39
▼
$176.41
$672.06B0.1813.97 million shs10.94 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
+0.83%+0.55%+1.92%+18.04%+32.78%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
+0.83%+0.55%+1.92%+18.04%+32.78%
Qualcomm Incorporated stock logo
QCOM
Qualcomm
+3.97%+13.65%+23.36%+6.64%+16.38%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
-0.96%-1.61%+1.45%+17.64%+40.08%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
-0.96%-1.61%+1.45%+17.64%+40.08%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$150.93
+0.8%
$141.81
$108.46
▼
$157.29
$185.61B0.335.64 million shs5.28 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$150.93
+0.8%
$141.81
$108.46
▼
$157.29
$185.61B0.335.64 million shs5.28 million shs
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$201.97
+4.0%
$170.18
$121.99
▼
$259.92
$204.02B1.6813.68 million shs17.80 million shs
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$160.48
-1.0%
$159.68
$110.39
▼
$176.41
$672.06B0.1813.97 million shs10.94 million shs
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$160.48
-1.0%
$159.68
$110.39
▼
$176.41
$672.06B0.1813.97 million shs10.94 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
+0.83%+0.55%+1.92%+18.04%+32.78%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
+0.83%+0.55%+1.92%+18.04%+32.78%
Qualcomm Incorporated stock logo
QCOM
Qualcomm
+3.97%+13.65%+23.36%+6.64%+16.38%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
-0.96%-1.61%+1.45%+17.64%+40.08%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
-0.96%-1.61%+1.45%+17.64%+40.08%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$158.785.20% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$158.785.20% Upside
Qualcomm Incorporated stock logo
QCOM
Qualcomm
2.34
Hold$204.101.06% Upside
ExxonMobil Corporation stock logo
XOM
ExxonMobil
2.48
Hold$164.262.36% Upside
ExxonMobil Corporation stock logo
XOM
ExxonMobil
2.48
Hold$164.262.36% Upside

Current Analyst Ratings Breakdown

Latest QCOM, GILD, XOM, XOM, and GILD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/25/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Set Price Target$172.00
9/25/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Reiterated RatingHold$90.00
9/25/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Set Price Target$172.00
9/25/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Reiterated RatingHold$90.00
9/22/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Boost Price TargetNeutral$168.00 ➝ $169.00
9/22/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Boost Price TargetNeutral$168.00 ➝ $169.00
9/21/2026
Qualcomm Incorporated stock logo
QCOM
Qualcomm
Reiterated RatingHold (C)
9/21/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Reiterated RatingSector Perform$160.00 ➝ $180.00
9/21/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
Reiterated RatingSector Perform$160.00 ➝ $180.00
9/15/2026
Qualcomm Incorporated stock logo
QCOM
Qualcomm
DowngradeHold ➝ Strong Sell
9/14/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
UpgradeHold (C-) ➝ Hold (C)
(Data available from 9/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B6.36$10.55 per share14.30$18.23 per share8.28
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B6.36$10.55 per share14.30$18.23 per share8.28
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$44.28B4.79$12.35 per share16.36$19.75 per share10.23
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$332.24B2.00$13.16 per share12.19$63.22 per share2.54
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$332.24B2.00$13.16 per share12.19$63.22 per share2.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B-$2.67N/A15.29N/A-10.64%-2.11%-0.75%10/29/2026 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B-$2.67N/A15.29N/A-10.64%-2.11%-0.75%10/29/2026 (Estimated)
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$5.54B$8.6423.3828.174.0521.01%38.36%17.48%11/4/2026 (Estimated)
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$28.84B$7.7720.6513.440.988.88%13.14%7.62%10/30/2026 (Estimated)
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$28.84B$7.7720.6513.440.988.88%13.14%7.62%10/30/2026 (Estimated)

Latest QCOM, GILD, XOM, XOM, and GILD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-$7.25-$6.75+$0.50-$8.45$7.40 billion$7.80 billion
8/3/2026Q2 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-$7.25-$6.75+$0.50-$8.45$7.40 billion$7.80 billion
7/31/2026Q2 2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$3.56$3.52-$0.04$3.48$109.94 billion$114.53 billion
7/31/2026Q2 2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$3.56$3.52-$0.04$3.48$109.94 billion$114.53 billion
7/29/2026Q3 2026
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$2.23$2.21-$0.02$1.87$9.69 billion$9.95 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.282.17%+3.04%N/A 10 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.282.17%+3.04%N/A 10 Years
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$3.681.82%+6.50%42.59%23 Years
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$4.122.57%+2.82%53.02%42 Years
ExxonMobil Corporation stock logo
XOM
ExxonMobil
$4.122.57%+2.82%53.02%42 Years

Latest QCOM, GILD, XOM, XOM, and GILD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.822.24%9/15/20269/15/20269/29/2026
7/28/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.822.24%9/15/20269/15/20269/29/2026
7/9/2026
Qualcomm Incorporated stock logo
QCOM
Qualcomm
quarterly$0.922.18%9/3/20269/3/20269/24/2026
7/30/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
quarterly$1.032.55%8/17/20268/17/20269/10/2026
7/30/2026
ExxonMobil Corporation stock logo
XOM
ExxonMobil
quarterly$1.032.55%8/17/20268/17/20269/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.03
1.27
1.09
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.03
1.27
1.09
Qualcomm Incorporated stock logo
QCOM
Qualcomm
0.46
2.02
1.28
ExxonMobil Corporation stock logo
XOM
ExxonMobil
0.12
1.13
0.85
ExxonMobil Corporation stock logo
XOM
ExxonMobil
0.12
1.13
0.85

Institutional Ownership

CompanyInstitutional Ownership
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Qualcomm Incorporated stock logo
QCOM
Qualcomm
74.35%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
61.80%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
61.80%

Insider Ownership

CompanyInsider Ownership
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
Qualcomm Incorporated stock logo
QCOM
Qualcomm
0.05%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
0.03%
ExxonMobil Corporation stock logo
XOM
ExxonMobil
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable
Qualcomm Incorporated stock logo
QCOM
Qualcomm
52,0001.05 billion1.05 billionOptionable
ExxonMobil Corporation stock logo
XOM
ExxonMobil
58,0004.14 billion4.14 billionOptionable
ExxonMobil Corporation stock logo
XOM
ExxonMobil
58,0004.14 billion4.14 billionOptionable

Recent News About These Companies

Exxon Mobil Issues Long-Dated Floating Rate Notes Offering
What Happens To ExxonMobil Stock If Refining Profits Fade?
ExxonMobil (NYSE:XOM) Shares Down 1% - What's Next?
Top Oil Stocks To Watch Now - September 25th
Vietnam’s BSR inks crude oil supply agreement with ExxonMobil
NTHM's Index Rebalance Puts Thematic Rotation to Work
ExxonMobil Corporation (NYSE:XOM) Stock Has Average Price Target of $167.30
Shale Tycoon Claims Exxon CEO ‘Betrayed’ Him in $60 Billion Deal
Caterpillar or Exxon: Which Dividend Has More Room to Grow?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$150.93 +1.24 (+0.83%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$150.81 -0.12 (-0.08%)
As of 09/25/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$150.93 +1.24 (+0.83%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$150.81 -0.12 (-0.08%)
As of 09/25/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Qualcomm stock logo

Qualcomm NASDAQ:QCOM

$201.97 +7.71 (+3.97%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$202.80 +0.83 (+0.41%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Qualcomm Incorporated engages in the development and commercialization of foundational technologies for the wireless industry worldwide. It operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies for use in wireless voice and data communications, networking, computing, multimedia, and position location products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of wireless products comprising products implementing CDMA2000, WCDMA, LTE and/or OFDMA-based 5G standards and their derivatives. The QSI segment invests in early-stage companies in various industries, including 5G, artificial intelligence, automotive, consumer, enterprise, cloud, IoT, and extended reality, and investments, including non-marketable equity securities and, to a lesser extent, marketable equity securities, and convertible debt instruments. It also provides development, and other services and related products to the United States government agencies and their contractors. The company was incorporated in 1985 and is headquartered in San Diego, California.

ExxonMobil stock logo

ExxonMobil NYSE:XOM

$160.48 -1.66 (-1.02%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$160.65 +0.17 (+0.11%)
As of 09/25/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ExxonMobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, catalysts, and licensing services. It sells its products under the Exxon, Esso, and Mobil brands. The Chemical Products segment manufactures and markets petrochemicals, including olefins, polyolefins, and intermediates. The Specialty Products segment offers performance products, including lubricants, basestocks, waxes, synthetics, elastomers, and resins. The company is also involved in the manufacturing, trade, transport, and selling crude oil, natural gas, petroleum products, petrochemicals, and other specialty products in pursuit of lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. Exxon Mobil Corporation was founded in 1870 and is based in Spring, Texas.

ExxonMobil stock logo

ExxonMobil NYSE:XOM

$160.48 -1.66 (-1.02%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$160.65 +0.17 (+0.11%)
As of 09/25/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ExxonMobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, catalysts, and licensing services. It sells its products under the Exxon, Esso, and Mobil brands. The Chemical Products segment manufactures and markets petrochemicals, including olefins, polyolefins, and intermediates. The Specialty Products segment offers performance products, including lubricants, basestocks, waxes, synthetics, elastomers, and resins. The company is also involved in the manufacturing, trade, transport, and selling crude oil, natural gas, petroleum products, petrochemicals, and other specialty products in pursuit of lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. Exxon Mobil Corporation was founded in 1870 and is based in Spring, Texas.